|Results 1 - 10 of 2740||Page 1 of 274|
|Results per-page: 10 | 20 | 50 | 100|
Relevance: 100% Posted on: 20th May 2015
Researchers in Cambridge are embarking on a pilot trial to investigate the potential of the hormone oxytocin to combat early symptoms of frontotemporal dementia (FTD), backed by a grant from Alzheimer’s Research UK. The UK’s leading dementia research charity, which is based in Great Abington near Cambridge, has awarded £29,827…
Relevance: 100% Posted on: 26th August 2015
Researchers in the US have investigated how a genetic mutation linked to frontotemporal dementia and motor neurone disease might lead to nerve cell damage in both conditions. The study, which made use of a range of techniques involving fruit flies as well as human cells, also highlights an approach that…
Relevance: 100% Posted on: 9th October 2012
US study reveals a potential biological mechanism involved in the disease.
Relevance: 100% Posted on: 6th August 2014
Scientists part-funded by Alzheimer’s Research UK have discovered how a specific genetic mutation may damage nerve cells in frontotemporal dementia and motor neurone disease.
Relevance: 100% Posted on: 9th October 2017
Researchers in the US have found that a protein called Lysine specific histone demethylase (LSD1) could protect against neurodegeneration in mice, and suggest that its function could be compromised in Alzheimer’s disease and frontotemporal dementia (FTD). The results of the study are published today in Nature Communications. LSD1 is a…
Relevance: 84% Posted on: 22nd April 2015
Researchers at the University of Pennsylvania have found that higher occupational attainment is associated with a longer survival from symptom onset in people with frontotemporal dementia. This study is published on 22 April in the journal American Academy of Neurology. Frontotemporal dementia is a rare form of dementia, but is…
Relevance: 84% Posted on: 14th September 2015
The Dementia Consortium, a unique charity-private partnership between Alzheimer’s Research UK, MRC Technology and the pharmaceutical companies Eisai and Lilly, has invested £305,000 in a new project to identify drugs for frontotemporal dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). A team at the International Centre for Genetic Engineering and Biotechnology…
Relevance: 84% Posted on: 21st January 2015
Frontotemporal dementia or FTD (sometimes called Pick’s disease) is a relatively rare form of dementia.
Relevance: 84% Posted on: 11th May 2012
This year's Manchester public meeting will focus on frontotemporal dementia, the second most common dementia in people under 65.
Relevance: 84% Posted on: 30th October 2013
Researchers at UCL Institute of Neurology have identified toxic molecules that are linked to a genetically-inherited form of frontotemporal dementia.